109 related articles for article (PubMed ID: 6681174)
1. [Bacterial antibodies and isoagglutinins in intravenous immunoglobulin preparations].
Haase M; Mengel H
Immun Infekt; 1983 Jun; 11(4):135-9. PubMed ID: 6681174
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antibacterial and antitoxic activity of normal human immunoglobulin for intravenous use (IVIG)].
Bucholc B; Banach W; Wysokińska T; Cieślik A; Chodorowska M
Med Dosw Mikrobiol; 1996; 48(1-2):87-94. PubMed ID: 8926773
[TBL] [Abstract][Full Text] [Related]
3. Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations.
Lejtenyi D; Mazer B
J Allergy Clin Immunol; 2008 Jan; 121(1):254-5. PubMed ID: 18206511
[No Abstract] [Full Text] [Related]
4. [Diagnostic use of the antistreptolysin O-test (AST) and the antistaphylolysin test (ASTA)].
Andersen BM
Tidsskr Nor Laegeforen; 1983 Jan; 103(3):194-6. PubMed ID: 6845317
[No Abstract] [Full Text] [Related]
5. Comparison of antibody content in human IgG and human IgG enriched with IgA.
Peeva Z
Dev Biol Stand; 1974; 27():58-61. PubMed ID: 4618537
[No Abstract] [Full Text] [Related]
6. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera.
Kristiansen M; Aggerbeck H; Heron I
APMIS; 1997 Nov; 105(11):843-53. PubMed ID: 9393555
[TBL] [Abstract][Full Text] [Related]
7. Clinical tetanus despite a protective level of toxin-neutralizing antibody.
Passen EL; Andersen BR
JAMA; 1986 Mar; 255(9):1171-3. PubMed ID: 2868135
[No Abstract] [Full Text] [Related]
8. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG].
Zakrzewska A; Rymkiewicz D
Przegl Epidemiol; 1995; 49(4):381-4. PubMed ID: 8868196
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of tetanus antitoxin after administration of specific immunoglobulins].
Crovari P; Gasparini R; Della Rocca A; D'Aste E
Boll Ist Sieroter Milan; 1980 Nov; 59(5):493-7. PubMed ID: 7248078
[TBL] [Abstract][Full Text] [Related]
10. Transplacental antibodies. Part II: Maternal antibodies against the toxins of C. diphtheriae and C. tetani.
Celko A; Burianová B; Kŕíz B; Zikmundová V; Zikmund V; Stríbrný J
J Hyg Epidemiol Microbiol Immunol; 1985; 29(1):83-8. PubMed ID: 3921608
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin: a review.
Eibl MM; Wedgwood RJ
Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
[TBL] [Abstract][Full Text] [Related]
12. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
Givner LB
Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
[TBL] [Abstract][Full Text] [Related]
13. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
[TBL] [Abstract][Full Text] [Related]
14. Immunological relation between serum antibodies against pneumolysin and against streptolysin O.
Kanclerski K; Granström M; Möllby R
Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):241-4. PubMed ID: 3673580
[TBL] [Abstract][Full Text] [Related]
15. [Study of the major antitoxin of equine serums (IgT), in relation to other immunoglobulins present in these serums].
Audibert F; Sandor G
Ann Inst Pasteur (Paris); 1972 Feb; 122(2):221-49. PubMed ID: 4114707
[No Abstract] [Full Text] [Related]
16. [Demonstration os isoagglutinins in intravenously applicable immunoglobulin preparations].
Strobel E; Wüllenweber J; Peters J
Beitr Infusionsther Transfusionsmed; 1994; 32():200-2. PubMed ID: 9480087
[TBL] [Abstract][Full Text] [Related]
17. The humoral immunity status of measles patients.
Nyerges G; Garami E; Kukán E
Acta Paediatr Acad Sci Hung; 1975; 16(2):111-7. PubMed ID: 180748
[No Abstract] [Full Text] [Related]
18. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
19. Anti-tetanus toxoid antibodies in intravenous gamma globulin: an alternative to tetanus immune globulin.
Lee DC; Lederman HM
J Infect Dis; 1992 Sep; 166(3):642-5. PubMed ID: 1500750
[TBL] [Abstract][Full Text] [Related]
20. [In vivo titration of antidiphtheria and antitetanus antibodies at various levels].
Relyveld EH
J Biol Stand; 1977; 5(1):45-55. PubMed ID: 838750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
